Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with D
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q2 2024 | DIETHYLENE GLYCOL MONO- AND DIPALMITOSTEARATE | VAGINAL | CREAM | 16500mg | Correction | ||
| Q3 2024 | DIETHYLENE GLYCOL MONO- AND DIPALMITOSTEARATE | VAGINAL | CREAM | 874mg | Correction | ||
| Q3 2024 | DEXTROSE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 1600.00 mg | Deletion | ||
| Q3 2024 | DEXTROSE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 1600.00 mg | 30144mg | Deletion | |
| Q2 2024 | D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | CAPSULE, DELAYED RELEASE | 0.30 mg | MDE Replacement | ||
| Q3 2024 | D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | CAPSULE, DELAYED RELEASE | 5mg | MDE Replacement | ||
| Q2 2024 | DC ANTIFOAM AF TRITURATION 1% ON SUCROSE | ORAL | POWDER, FOR SOLUTION | 2.63 mg/ 1.00 ml | MDE Replacement | ||
| Q3 2024 | DC ANTIFOAM AF TRITURATION 1% ON SUCROSE | ORAL | POWDER, FOR SOLUTION | 210mg | MDE Replacement | ||
| Q2 2024 | DIISOPROPYL ADIPATE | TOPICAL | AEROSOL, FOAM | 5.00 %w/w | MDE Replacement | ||
| Q3 2024 | DIISOPROPYL ADIPATE | TOPICAL | AEROSOL, FOAM | 200mg | MDE Replacement | ||
| Q2 2024 | DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | CAPSULE | 4.52 mg | MDE Replacement | ||
| Q3 2024 | DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | CAPSULE | 72mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024